| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/18/2007 | CN100998794A Oral administration Chinese medicine for treating lower wanner damp-heat night sweat |
| 07/18/2007 | CN100998793A Oral traditional Chinese medicine for treating damp-heat and impairment of yin type serious sweat disease |
| 07/18/2007 | CN100998789A Powder medicine for strengthening body resistance and removing turbid qi |
| 07/18/2007 | CN100998744A Chinese patent drug for treating infantile hyperkinetic syndrome |
| 07/18/2007 | CN100998610A Antifatigue medicine contg. ombrophyte red chlorella |
| 07/18/2007 | CN100998584A Medicine composition used for injection and its preparing method |
| 07/18/2007 | CN100998430A Method for making thin cake containing degreased peanut |
| 07/18/2007 | CN100998378A Bait used specially for atlantic trout |
| 07/17/2007 | US7244861 Insulin sensitizer; antidiabetic agents; antiproliferative agents; antiinflammatory agents |
| 07/17/2007 | US7244848 N-[4-[(1E)-3-amino-1-propenyl]phenyl]-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamide; for treatment of hyperlipidemia, obesity and type II diabetes |
| 07/17/2007 | US7244846 Substituted benzofuran-2-carboxamides derivatives |
| 07/17/2007 | US7244830 having a polymer backbone; a first pendent unit comprising a linking group connected to said polymer backbone and a saccharide moiety connected to said linking group |
| 07/17/2007 | US7244818 Interferon alpha responsive protein |
| 07/17/2007 | US7244761 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient |
| 07/17/2007 | US7244760 Methods for preparation and use of psorospermin analogs |
| 07/17/2007 | US7244756 For increasing blood-brain barrier permeability |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/17/2007 | US7244752 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | US7244729 tyrosine kinase inhibitors; for the treatment especially of a proliferative disease, such as a tumur |
| 07/17/2007 | US7244726 Heterocyclic compounds possessing affinity at 5HT1 -type receptors and use thereof in therapy |
| 07/17/2007 | US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 07/17/2007 | US7244721 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 07/17/2007 | US7244718 Derivatives of water insoluble drugs which exhibit good activity and water solubility; producing an anesthetic effect in a dog |
| 07/17/2007 | US7244711 Mixtures of enzyme inhibitors and free radical scavengers selected from phenolic compounds, phenothiazines and diphenylamines, used for prophylaxis of rheumatic diseases, pancreatitis, multiple sclerosis or gastrointestinal disorders |
| 07/17/2007 | US7244708 Inhibitors of memapsin 2 and use thereof |
| 07/17/2007 | US7244449 Liposome-entrapped topoisomerase inhibitors |
| 07/17/2007 | US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 07/17/2007 | US7244414 Administering fine powder of active material; measured aerosol |
| 07/17/2007 | CA2485834C Pseudopolymorphic forms of a hiv protease inhibitor |
| 07/17/2007 | CA2432643C 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 07/17/2007 | CA2395558C Intermediates for 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 07/17/2007 | CA2388639C Inhibitors of .alpha.l.beta.2 mediated cell adhesion |
| 07/17/2007 | CA2373944C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 07/17/2007 | CA2321369C Dosing regimens for lasofoxifene |
| 07/17/2007 | CA2298445C Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 07/17/2007 | CA2285542C N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation |
| 07/17/2007 | CA2283198C Butyrate prodrugs derived from lactic acid |
| 07/17/2007 | CA2254528C Treatment of ischemia reperfusion injury and treatment of cellular dysfunction including arrhythmia and heart failure subsequent to myocardial infarction |
| 07/17/2007 | CA2160161C Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors |
| 07/12/2007 | WO2007077861A1 NF-κB INHIBITOR |
| 07/12/2007 | WO2007077812A1 Pharmaceutical having anti-histamine activity |
| 07/12/2007 | WO2007077656A1 Liquid medicine for internal use |
| 07/12/2007 | WO2007077445A1 Method of diagnosis of a predisposition to laminitis |
| 07/12/2007 | WO2007077365A2 IMMUNOGLOBULIN G (IgG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES AND OF POLYREACTIVE IgGs |
| 07/12/2007 | WO2007057571A3 3-acylindole derivatives the preparation and the therapeutic use thereof |
| 07/12/2007 | WO2007047725A3 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 07/12/2007 | WO2007047575A3 Pharmacological treatments for sleep-related breathing disorders |
| 07/12/2007 | WO2006110406A3 Compositions comprising probiotic and sweetener components |
| 07/12/2007 | WO2006096800A8 Immunogenic t cell targets in autoimmune hepatitis and methods of use |
| 07/12/2007 | US20070161712 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene |
| 07/12/2007 | US20070161702 Abca1 stabilizer |
| 07/12/2007 | US20070161681 Ether derivatives useful as inhibitors of pde4 isozymes |
| 07/12/2007 | US20070161667 Process for preparing inhibitors of nucleoside metabolism |
| 07/12/2007 | US20070161666 Pyrrolo[2,3-d]pyrimidine compounds |
| 07/12/2007 | US20070161649 e.g. 6-Methoxy-(4-benzylpiperidinyl)-indole-5-carboxamide-3-glyoxalic acid; antiinflammatory, antiproliferative agent; neurodegenerative diseases |
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) |
| 07/12/2007 | US20070161640 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 07/12/2007 | US20070161635 Kinase inhibitors |
| 07/12/2007 | US20070161632 Tyrosine kinase inhibitors; antiproliferative agents; antitumor agents |
| 07/12/2007 | US20070161621 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/12/2007 | US20070161620 Isoquinoline compound and pharmaceutical use thereof |
| 07/12/2007 | US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 07/12/2007 | US20070161602 Phosphonate compounds |
| 07/12/2007 | US20070161557 Increasing hematopoiesis; treating glucosuria, hyperglycemia and diabetes; thrombocytopenia |
| 07/12/2007 | US20070161555 Administering adrenomedullin for inhibiting abnormal bradykinin-induced myometrial contraction |
| 07/12/2007 | US20070161549 Glycosylation-deficient hepatocyte growth factor |
| 07/12/2007 | US20070161063 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/12/2007 | US20070161046 Truncated aggrecanase molecules |
| 07/12/2007 | US20070160666 comprises cholesterol absorption inhibitor (ezetimibe) and HMG-CoA reductase inhibitor (simvastatin), antioxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose; free of ascorbic acid and pregelatinized starch; for treatment of atheroslerosis; stability |
| 07/12/2007 | US20070160614 Human TIMP-1 antibodies |
| 07/12/2007 | US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL) |
| 07/12/2007 | US20070160600 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
| 07/12/2007 | US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders |
| 07/12/2007 | US20070160593 Sugar chain-cleaving agent |
| 07/12/2007 | US20070160570 Chimeric polypeptides containing chemokine domains |
| 07/12/2007 | US20070160567 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 07/12/2007 | US20070160558 Peptide composition |
| 07/12/2007 | US20070160545 Method for reducing ultraviolet light induced apoptosis |
| 07/12/2007 | US20070160539 HPRP4s Modifiers of the p53 Pathway and Methods of Use |
| 07/12/2007 | US20070160537 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia |
| 07/12/2007 | US20070160534 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands |
| 07/12/2007 | DE60125335T2 Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten Azacyclic compounds for use in the treatment of serotonin-related diseases |
| 07/12/2007 | CA2634997A1 Immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies and of polyreactive iggs |
| 07/11/2007 | EP1806367A2 Polymers containing polysaccharides such as alginates or modified alginates |
| 07/11/2007 | EP1806347A1 Aromatic-ring-fused pyrimidine derivative |
| 07/11/2007 | EP1806149A1 Solid medicinal preparation improved in solubility and stability and process for producing the same |
| 07/11/2007 | EP1806144A2 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 07/11/2007 | EP1806143A2 Baff receptor (BCMA), an immunoregulatory agent |
| 07/11/2007 | EP1806138A1 Anti-tumor agents comprising boroproline compounds |
| 07/11/2007 | EP1806134A1 Agent and food for preventing/improving functional digestive disorder |
| 07/11/2007 | EP1806132A1 STAT3 PHOSPHORYLATION INHIBITOR AND Notch1 EXPRESSION INHIBITOR |
| 07/11/2007 | EP1804797A1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
| 07/11/2007 | EP1535065A4 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 07/11/2007 | EP1497287A4 Quinolinone derivatives |
| 07/11/2007 | EP1461361B1 Negatively charged polysaccharide derivable from aloe vera |
| 07/11/2007 | EP1458706B1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/11/2007 | EP1455808B1 Phosphinate-peptide analogues as inhibitors of procollagen-c-proteinase (pcp) for treating fibrotic diseases |
| 07/11/2007 | EP1366021B1 Substituted diarylureas as stimulators for fas-mediated apoptosis |